HBS1L-MYB rs9399137: What Your Genotype Means
The rs9399137 variant is a single-nucleotide polymorphism located in the intergenic region between the HBS1L and MYB genes on chromosome 6. It is widely studied for its association with the regulation of fetal hemoglobin (HbF) levels and its potential influence on clinical severity in individuals with sickle cell anemia.
What each genotype means
Baseline fetal hemoglobin levels
This genotype is associated with lower baseline levels of fetal hemoglobin compared to carriers of the T allele. Research indicates that this variant in the HBS1L-MYB region acts as a quantitative trait locus for fetal hemoglobin, which can influence clinical severity in individuals with sickle cell anaemia.
This is a common genotype, though exact frequencies vary significantly by ancestral background.
Intermediate fetal hemoglobin levels
Individuals with this genotype typically show intermediate levels of fetal hemoglobin compared to those with the C/C or T/T genotypes. This variant is part of a genetic regulatory region that influences hemoglobin expression, and its effect on clinical outcomes is most studied in the context of sickle cell anaemia.
This heterozygous genotype is frequently observed across diverse global populations.
Elevated fetal hemoglobin levels
This genotype is associated with higher levels of fetal hemoglobin, which is a known modifier of clinical severity in sickle cell anaemia. While this association is statistically significant in research cohorts, it is one of several genetic and environmental factors that influence hemoglobin levels; it is not a diagnostic indicator.
This genotype is common, with the T allele appearing at a global minor allele frequency of approximately 20.8%.
Understanding the Variant and Its Location
The rs9399137 variant is a genetic marker situated within the 126 kb intergenic region between the HBS1L and MYB genes on chromosome 6q23. This specific area is known as a quantitative trait locus, meaning it contains genetic sequences that influence the levels of measurable traits, such as the amount of fetal hemoglobin in the blood. Research indicates that this region acts as a regulatory hub for erythroid cell development. The variant rs9399137 is often studied alongside other nearby polymorphisms, including a 3-bp deletion that is in strong linkage disequilibrium with this SNP. Because it sits in a non-coding region, it does not change the structure of a protein directly; instead, it is thought to affect how nearby genes are turned on or off by influencing enhancer elements that interact with the MYB transcription factor.
The Role of HBS1L and MYB
The genes flanking this variant, HBS1L and MYB, are critical to blood cell production. MYB encodes a transcription factor that is essential for the maturation of red blood cells. Studies have shown that the expression levels of MYB are inversely related to fetal hemoglobin production; when MYB activity is modulated, it can lead to changes in the levels of HbF. HBS1L, a member of the GTP-binding elongation factor family, is also expressed in erythroid progenitor cells. The intergenic region between these two genes contains regulatory sequences that act as long-range enhancers for MYB. By altering these regulatory elements, variants like rs9399137 can influence the expression of MYB, which in turn modulates the production of fetal hemoglobin. This mechanism is a primary focus for researchers looking to understand how genetic variation contributes to the diversity of hemoglobin levels in the human population.
Research Associations and Evidence Strength
The association between rs9399137 and fetal hemoglobin levels has been observed across various populations, including European, Asian, and African American cohorts. In the context of sickle cell anemia, higher levels of fetal hemoglobin are generally associated with milder clinical symptoms, as HbF can inhibit the sickling of red blood cells. Consequently, researchers have investigated whether this variant can help predict clinical outcomes, such as the risk of stroke or acute chest syndrome. While the statistical association between this variant and HbF levels is well-documented in the literature, the evidence regarding its direct impact on clinical severity is considered limited and often requires the consideration of other genetic modifiers, such as those at the BCL11A locus. It is important to note that genetic risk scores are tools for research and population studies, not diagnostic instruments for individual clinical management.
What You Can and Cannot Do With This Information
Understanding your genotype for rs9399137 provides insight into your genetic predisposition regarding fetal hemoglobin regulation, but it does not provide a medical diagnosis. This information is intended for educational purposes and should not be used to make decisions about your health or medical treatment. If you have concerns about sickle cell anemia or other blood-related conditions, it is essential to consult with a qualified healthcare professional or a genetic counselor. They can interpret your results in the context of your overall health, family history, and other clinical factors. Never use genetic information to alter or stop any prescribed medications or treatments without first discussing these changes with your clinician or pharmacist. Genetic associations are complex and influenced by many factors, and individual health outcomes are determined by a combination of genetics, environment, and lifestyle.
How common is this variant?
The rs9399137 variant is considered a common polymorphism, though its minor allele frequency varies significantly across different ancestral populations.
Frequently asked questions
What is the HBS1L-MYB region?
The HBS1L-MYB region is a segment of DNA on chromosome 6 that contains regulatory elements controlling the production of fetal hemoglobin. It is a well-known quantitative trait locus that influences how red blood cells develop.
Does rs9399137 cause sickle cell disease?
No, rs9399137 does not cause sickle cell disease. It is a genetic modifier that may influence the severity of the condition by affecting fetal hemoglobin levels, but it is not the underlying cause of the disease itself.
Can I use this SNP to predict my health?
No, this SNP cannot be used to predict your health. Genetic associations are statistical observations across large groups and cannot account for the complex interplay of individual health factors, environment, and other genes.
Should I change my medication based on this result?
You should never change your medication based on genetic test results. Always consult with your doctor or pharmacist before making any changes to your prescribed treatment plan.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9399137?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29